HM
HealthCor Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,930
| Closed | -$1.06M | – | 67 |
|
|
2022
Q1 | $1.06M | Buy |
+13,930
| New | +$1.06M | 0.07% | 56 |
|
|
2020
Q3 | – | Sell |
-405,040
| Closed | -$21.3M | – | 53 |
|
|
2020
Q2 | $21.3M | Sell |
405,040
-482,330
| -54% | -$25.3M | 0.89% | 33 |
|
|
2020
Q1 | $29.8M | Buy |
887,370
+116,230
| +15% | +$3.9M | 1.27% | 26 |
|
|
2019
Q4 | $34.9M | Buy |
+771,140
| New | +$34.9M | 1.25% | 32 |
|
|
2019
Q2 | – | Sell |
-706,379
| Closed | -$26.9M | – | 61 |
|
|
2019
Q1 | $26.9M | Sell |
706,379
-1,791,749
| -72% | -$68.2M | 1.09% | 31 |
|
|
2018
Q4 | $107M | Buy |
2,498,128
+552,588
| +28% | +$23.8M | 3.36% | 12 |
|
|
2018
Q3 | $95.6M | Sell |
1,945,540
-909,673
| -32% | -$44.7M | 3.17% | 12 |
|
|
2018
Q2 | $91.5M | Buy |
2,855,213
+555,213
| +24% | +$17.8M | 2.91% | 11 |
|
|
2018
Q1 | $71.6M | Sell |
2,300,000
-500,000
| -18% | -$15.6M | 2.44% | 11 |
|
|
2017
Q4 | $128M | Buy |
2,800,000
+221,960
| +9% | +$10.1M | 4.16% | 9 |
|
|
2017
Q3 | $96.8M | Buy |
2,578,040
+784,241
| +44% | +$29.4M | 3.24% | 9 |
|
|
2017
Q2 | $85.6M | Buy |
1,793,799
+693,799
| +63% | +$33.1M | 3.09% | 10 |
|
|
2017
Q1 | $50.2M | Sell |
1,100,000
-475,000
| -30% | -$21.7M | 2.3% | 15 |
|
|
2016
Q4 | $50.9M | Buy |
1,575,000
+830,720
| +112% | +$26.8M | 2.87% | 15 |
|
|
2016
Q3 | $25.5M | Buy |
744,280
+494,280
| +198% | +$16.9M | 1.55% | 21 |
|
|
2016
Q2 | $8.43M | Buy |
+250,000
| New | +$8.43M | 0.46% | 34 |
|
|
2016
Q1 | – | Sell |
-21,500
| Closed | -$1.65M | – | 48 |
|
|
2015
Q4 | $1.65M | Buy |
+21,500
| New | +$1.65M | 0.1% | 37 |
|
|
2015
Q1 | – | Sell |
-125,000
| Closed | -$11.1M | – | 63 |
|
|
2014
Q4 | $11.1M | Buy |
+125,000
| New | +$11.1M | 0.62% | 31 |
|